Role of ERK and JNK pathways in regulating cell motility and matrix metalloproteinase 9 production in growth factor-stimulated human epidermal keratinocytes by Zeigler, Mary E. et al.
Role of ERK and JNK Pathways in Regulating
Cell Motility and Matrix Metalloproteinase 9
Production in Growth Factor-Stimulated
Human Epidermal Keratinocytes
MARY E. ZEIGLER,* YIQING CHI, TANJA SCHMIDT, AND JAMES VARANI
Department of Pathology, The University of Michigan Medical School,
Ann Arbor, Michigan
Invasion is an essential cellular response that plays an important role in a number
of physiological and pathological processes. Matrix metalloproteinase (MMP)
production and cell movement are diverse cellular responses integral to the
process of invasion. The complexity of the invasive process suggests the necessity
of coordinate activation of more than one signaling pathway in order to activate
specific factors responsible for regulating these cellular responses. In this report,
we demonstrate that cell movement and MMP-9 production are both directly
dependent on the activation of endogenous ERK signaling in hepatocyte growth
factor (HGF)-or epidermal growth factor (EGF)-stimulated human epidermal ke-
ratinocytes. The kinetic profiles of endogenous MEK and ERK activity suggest that
prolonged activation of these signal transducers is an underlying mechanism
involved in stimulating cell motility and MMP-9 production. In support of this
finding, a transient MEK/ERK signal elicited by keratinocyte growth factor (KGF) or
insulin-like growth factor-1 (IGF-1) fails to stimulate these invasion-related re-
sponses. Specific inhibition of MEK leads to suppression of ERK activation,
marked reduction in steady-state levels of c-Fos, and inhibition of cell movement
and MMP-9 production. This occurs despite continued activation of JNK and
c-Jun signaling in the presence of MEK-specific inhibition. In contrast, when JNK
activity is specifically inhibited in HGF-stimulated cells, AP-1 activity is sup-
pressed but cell motility is not affected. This evidence suggests that while ERK and
JNK activity are necessary for AP-1 activation, ERK but not JNK is sufficient in
stimulating cell motility. J. Cell. Physiol. 180:271–284, 1999.
© 1999 Wiley-Liss, Inc.
Invasion plays an important role in a number of
diverse physiological and pathological processes such
as tissue remodeling associated with embryonic devel-
opment (Symes et al., 1996), tissue regeneration and
wound repair (Henke et al., 1996), angiogenesis (Ca-
mussi et al., 1997), and tumor metastasis (Stetler-
Stevenson et al., 1993). In studies conducted in a num-
ber of experimental models, it appears that matrix
metalloproteinase (MMP) production and cell move-
ment are essential components of the invasion process
(DeClerk et al., 1992; Liotta et al., 1979; Aznavoorian
et al., 1996). In vivo, these invasive properties may be
induced by a variety of stimuli including growth fac-
tors. Several growth factors including hepatocyte
growth factor/scatter factor (HGF; Park et al., 1987;
Komada and Kitmura, 1993; Bottaro et al., 1991;
Weidner et al., 1993; Hartmann et al., 1992; Rong et
al., 1992; Giordano et al., 1993), epidermal growth fac-
tor (EGF; McCawley et al., 1997; Price et al., 1996),
insulin-like growth factor-1 (IGF-1; Jiang et al., 1996;
Doerr and Jones, 1996), and keratinocyte growth factor
(KGF; Marchese et al., 1990; Sato et al., 1995) have
been shown to stimulate proliferative responses and to
induce cell molility and/or the production of MMPs in
vivo or in vitro in various cell types.
Because human epidermal squamous epithelial cells
(keratinocytes) are known to be responsive to prolifer-
ative stimulation by these growth factors, we were able
to assess the relative potency of these proliferative
factors in inducing invasion of the dermis by epidermal
keratinocytes. Using human skin explants (Fligiel and
Varani, 1993; Varani et al., 1994, 1995) as an in situ
model for studying mechanisms underlying growth fac-
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tor-dependent cell invasion, we determined that, in
contrast to KGF or IGF-1 which did not stimulate in-
vasion, HGF or EGF stimulated epidermal keratino-
cytes to invade the dermis (Zeigler et al., 1996a). This
was inspite of the fact that all four growth factors
induced a comparable proliferative response in these
cells. We subsequently found that the invasion-promot-
ing growth factors, HGF or EGF, unlike KGF or IGF,
were potent stimulators of keratinocyte motility and
MMP-9 production in these cells but not in dermal
fibroblasts (Zeigler et al., 1996a,b). These finding sug-
gested that cell motility and MMP production are in-
vasion-promoting properties functionally linked to
HGF- or EGF-stimulated epidermal keratinocyte inva-
sion of the dermis.
The differences in the capacity of these growth fac-
tors to stimulate cellular properties associated with
invasion suggested that comparative studies could be
used to advantage as a basis for delineating the growth
factor-dependent regulatory mechanisms that “drive”
these responses. These differences may be due, in part,
to differences in the kinetic properties of the signaling
pathway(s) activated by HGF or EGF stimulation of
their respective receptor protein tyrosine kinases
(RTK) as compared to signals transmitted via these
same pathways by KGF or IGF-activated RTKs. Recent
evidence suggests that differences in the properties of
the transmitted signal stimulated by nerve growth fac-
tor as compared to EGF in the same cell type may be a
key factor in determining whether these cells prolifer-
ate or differentiate (Traverse et al., 1992, 1994).
The AP-1 transcription complex appears to play an
essential role in stimulating transcriptional activation
of several MMPs including MMP-9 (Sato and Seiki,
1993; Gum et al., 1996). In its active form, the AP-1
complex may comprise homodimers of c-Jun or het-
erodimers between c-Fos, c-Jun, and ATF2 (Karin et
al., 1997; Smeal et al., 1989; Whisler et al., 1997). c-Jun
proteins are activated by N-terminal phosphorylation
of specific serine residues (Ser63/73) that appear to be
exclusively activated by jun-N-terminal kinases
(JNKs), also known as stress-activated protein kinases
(SAPKs). It has, therefore, been suggested that the
JNK pathway is necessary in mediating MMP-9 pro-
duction (Gum et al., 1997). However, c-Fos activation is
not as strictly regulated. In this regard, the transcrip-
tion factor, Elk-1, when phosphorylated induces c-Fos
transcription which can be mediated either by activa-
tion of JNK or extracellular-regulated protein kinase
(ERK) depending on cell type and cellular stimuli (Cav-
igelli et al., 1995).
It is likely that the ERK and JNK pathways are
activated and work in concert to stimulate properties
functionally linked to the growth factor-dependent in-
vasive response in human epidermal keratinocytes.
However, the exact mechanisms underlying the signal-
ing properties of the endogenous ERK and JNK path-
ways that mediate the activation of these invasion-
promoting cellular responses are not clearly defined;
nor is it clear as to whether each of these pathways is
necessary for stimulating both MMP-9 production and
cell motility.
In this report, we examined in low-passage normal
human keratinocytes, MAPK signaling in response to
treatment either with HGF, EGF, KGF, or IGF-1. Con-
comitantly, we examined the effects of interfering with




Commercial sources of reagents are as follows: kera-
tinocyte growth medium (KGM), consisting of a kera-
tinocyte basal medium (KBM) supplemented with
EGF, insulin, hydrocortisone, and bovine pituitary ex-
tract, from Clonetics Corp. (San Diego, CA); HGF,
EGF, KGF, and IGF-1 from R&D Systems (Minneapo-
lis, MN); sodium vanadate and 104 phosphate sub-
strate from Sigma (St. Louis, MO); aprotinin, leupep-
tin, and pepstatin from Boeringher Mannheim
(Indianapolis, IN); OPTITRAN (BA-S 85) nitrocellulose
transfer membranes from Schleicher and Schuell
(Keene, ME); MEK1-and MEK2-specific antibodies
from Transduction Laboratories (Lexington, KY); phos-
pho-specific ERK1/2 antibody (detects ERK1 and ERK2
only when activated by phosphorylation at Tyr204),
phospho-specific SAPK/JNK antibody (detects three
isoforms of SAPK/JNK only when activated by phos-
phorylation at Thr183/Tyr185), phospho-specific Elk-1
antibody (detects Elk-1 only when activated by phos-
phorylation at Ser383) and phospho-specific c-Jun an-
tibody (detects only activated c-Jun when phosphory-
lated at Ser63), recombinant ERK2 fusion protein
previously phosphorylated at Tyr204 after treatment
with MEK1/2 in vitro and purified free of nonphospho-
rylated ERK1/2, GST-ELK-1 fusion protein (containing
Elk-1 codons 307-428, encompassing the activating
Ser383 amino acid critical to its transcription activity)
and GST-c-Jun fusion protein (containing c-Jun codons
1-89, encompassing the activating Ser63/73 amino ac-
ids), Phototope-HRP Western detection kit containing
LumiGlo reagent, and MEK inhibitor (PD098059) from
New England Biolabs (Beverly MA); GST-ERK2 fusion
protein (mouse p42 MAP Kinase-GST, expressed in
Escherichia coli, serves as substrate for MEK kinase
activity and exhibits kinase activity toward Elk-1) and
GST-JNK fusion protein (rat SAP Kinase a-GST aga-
rose conjugate, serves as a substrate for SEK kinase
activity and exhibits SEK-dependent kinase activity
toward c-Jun) from Upstate Biotechnology Inc. (Lake
Placid, NY); protein A-conjugated Sepharose CL-4B
from Pharmacia (Uppsala, Sweden); SEK (MKK4)-spe-
cific antibody, antibody to JNK1(also crossreacts with
JNK2), and ERK1 and ERK2 antibodies from Santa
Cruz Biotechnology, Inc. (Santa Cruz, CA); FLAG an-
tibody from Research Diagnostics Inc. (Flanders, NJ).
Cell cultures
Early passage cultures of human epidermal keratin-
ocytes were isolated either from keratome strips ob-
tained from adult volunteers or from neonatal fore-
skins according to the procedure of Boyce and Ham
(1983). Primary or early passage cultures of human
keratinocytes were grown in KGM. Cells were cultured
at 37°C at a constant level of 5% CO2/95% air in a
humidified incubator. Keratinocytes were routinely
passaged after reaching 60% to 70% confluency and
were typically used at passage 2 to 4. When measuring
the time-dependent phosphorylation or kinase activity
of MEK, ERK, SEK, JNK, and c-Jun, early passage
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keratinocytes were first plated at 1.5 3 105 cells per
60-mm culture dish. After 36 h of growth in KGM, the
medium was withdrawn, cells were rinsed in KBM, and
cultured in KBM for 6–7 h. The keratinocytes were
subsequently cultured in the presence or absence of 3.5
nM HGF, 1.6 nM EGF, 6.7 nM IGF-1, or 15.8 nM KGF;
these doses of reagents were previously determined to
be optimal in stimulating epidermal invasion of the
dermis in organ culture and in stimulating prolifera-
tion, MMP production, and motility of keratinocytes in
culture (Zeigler et al., 1996a,b). Cells were subse-
quently harvested as described below.
Preparation of cell lysates
Following treatment of keratinocyte cultures with
growth factors, cell lysates were prepared at the times
indicated in the figure legends. Cells were lysed in 13
buffer consisting of 20 mM Tris-HCl (pH 7.4), 2 mM
sodium vanadate, 1.0 mM sodium fluoride, 100 mM
NaCl, 2.0 mM 104 phosphate substrate, 1% NP40, 0.5%
sodium deoxycholate, 25.0 mg/ml each aprotinin and
leupeptin, 25.0 mg/ml pepstatin, 2.0 mM each EDTA
and EGTA. Lysis was performed at 4°C by scraping
cells and then fragmenting cellular debris by several
passes through a 26-gauge needle. Cell lysates were
cleared by microcentrifugation at 12,0003 g following
incubation at 4°C for 25 min. The supernatant was
recovered and the protein concentration of the lysates
measured using the BioRad protein assay reagent (Bio-
Rad, Hercules, CA).
Detection of MEK, ERK, SEK, and JNK
phosphorylation by Western blot
Equivalent amounts of cell lysate protein (100 mg)
were resolved by sodium dodecyl sulfate-polyacrylam-
ide gel electrophoresis (SDS-PAGE; 12%). Proteins
were transferred to nitrocellulose membranes by elec-
troblotting using a BioRad mini transfer blotting ap-
paratus. Membranes were subsequently blocked in
Ca21/Mg21-free Tris-buffered saline (TBS), containing
5% Blotto. Membranes were then treated with phos-
phorylation state-specific ERK1/2 antibody at a 1:1,000
dilution in 0.5% Blotto, TBS, and 0.1% Tween for 1 h.
Following several rinses in TBS, 0.1% Tween, the
membrane-bound phosphorylated ERK1/2 protein was
reacted with horseradish peroxidase (HRP)-conjugated
goat anti-rabbit antibody at a 1:2,000 dilution for 1 h.
Phosphorylated ERK protein was detected by chemilu-
minescence involving treatment of the membrane with
LumiGlo reagent and capture of light emissions to X-
ray film. The kinetics of ERK phosphorylation was
quantified and depicted in graphic format after densi-
tometric analysis of scanned x-ray images using the
SHARP JX-320 scanner and the NIH Image analysis
software program. Three to four exposures of immuno-
blots at specific intervals were taken in order to ensure
that the band intensities of exposures depicted in each
figure were within the linear range of detection by
densitometry scanning. Changes in the levels of phos-
phorylation of ERK were depicted as a fold increase
relative to T0 phosphorylation levels as a function of
time. Phosphorylated MEK, JNK, and c-Jun proteins
were detected in the same way, using samples of the
same lysates previously used for detection of ERK1/2
phosphorylation, and depicted in the same graphic for-
mat as for ERK. The phospho-specific primary antibod-
ies detected only the phosphorylated form of each pro-
tein and did not crossreact with any of the other
phosphoproteins. The steady-state levels of MEK,
ERK, SEK/MKK4, JNK, and c-Jun proteins were mea-
sured using phosphorylation state-independent anti-
bodies specific to each of these proteins.
ERK kinase activity assay and MEK kinase
cascade assay
To verify the kinetics of the kinase active state of
ERK, 300 mg of cell lysate protein was immunoprecipi-
tated with phospho-specific ERK antibody at a 1:100
dilution in 13 lysis buffer at 4°C for 16 h. The immune
complex was recovered by treatment for 3 h at 4°C with
protein A-conjugated Sepharose CL-4B, previously hy-
drated in phosphate-buffered saline (PBS). After sev-
eral washes in 13 lysis buffer, the pellet was subse-
quently rinsed in 13 kinase buffer (25 mM Tris [pH
7.5], 5 mM b-glycerolphosphate, 2 mM dithiothreitol
[DTT], 0.1 mM sodium vanadate, and 10 mM MgCl2),
then resuspended in kinase buffer containing 1 mg of
GST-Elk-1 substrate and 100 mM ATP. The reaction
proceeded for 30 min, was terminated by the addition
of SDS loading buffer, boiled for 5 min, and resolved by
SDS-PAGE (12%). Immunoblotting was performed as
described above, except that phosphorylated GST-
Elk-1 was detected using phospho-specific Elk-1 anti-
body. The positive control consisted of in vitro phos-
phorylation of GST-Elk-1 by active recombinant ERK2
previously added to and immunoprecipitated from time
zero lysate protein with phosphospecific ERK antibody.
The kinetics of ERK phosphorylation is depicted in
graphic format after scanning densitometry as de-
scribed above.
To evaluate MEK kinase activity in samples of these
same lysates, a kinase cascade assay was performed in
which MEK was immunoprecipitated in 300 mg of cell
lysate using 0.5 mg/ml each of MEK1- and MEK2-spe-
cific antibody. The immune complex was recovered and
the kinase reaction performed as described above, ex-
cept that a MEK subtrate, GST-ERK2 (mouse p42
MAP Kinase-GST) was included in the reaction. After
30 min, nonphosphorylated GST-Elk-1 substrate was
added to the reaction which then proceeded for 30 min.
After the reaction was terminated by addition of SDS
loading buffer, the samples were subjected to SDS-
PAGE (12%) and immunoblotted. Controls for this ki-
nase cascade assay included reacting immunoprecipi-
tated MEK with GST-Elk-1 only or reacting only GST-
ERK with GST-Elk-1 to test the level of GST-ERK
autoactivation in the absence of endogenous activated
MEK1/2.
SEK and JNK kinase activity assay
Cell lysates were prepared from early passage kera-
tinocytes stimulated with HGF or KGF for 0, 2, 10, 30,
and 60 min. The kinetics of activation of endogenous
SEK was assessed using a kinase cascade assay in
which 3 mg of GST-JNK substrate conjugated to aga-
rose beads was reacted with 250 mg of cell lysate pro-
tein in lysis buffer at 4°C for 3 h. The substrate was
recovered by centrifugation, washed extensively in ly-
sate buffer, rinsed, and reacted in kinase buffer with
GST-c-Jun substrate to test the extent of kinase acti-
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vation by endogenous SEK. The extent of phosphory-
lation of GST-c-Jun by SEK-activated GST-JNK sub-
strate was assayed by immunoblot using phospho-
specific c-Jun antibody. Controls included a) reaction of
GST-JNK with GST-c-Jun in the absence of SEK con-
taining lysate protein to test the levels of GST-JNK
autoactivation and b) testing the levels of the phos-
phorylated GST-c-Jun in the absence of GST-JNK. The
background level of SEK-independent phosphorylation
of GST-c-Jun by GST-JNK (lane, GST-JNK 1 GST-c-
Jun) was substracted in the scanning densitometry
depicting the kinetics of SEK kinase activity.
To confirm that the activation of GST-JNK is depen-
dent on kinase active endogenous SEK, SEK was im-
munoprecipitated with SEK-specific antibody from
samples of the same lysate protein referred to imme-
diately above. The SEK-specific immune complex was
recovered by centrifugation, after the addition of pro-
tein A-conjugated Sepharose CL-4B. Samples of the
reserved lysate protein solution, which were from sam-
ples treated with HGF at 0, 2, and 10 min, were sub-
sequently combined with 3 mg GST-JNK agarose-con-
jugated substrate and reacted for 3 h at 4°C in lysis
buffer. After recovery of the substrate by centrifuga-
tion, the GST-JNK substrate was washed extensively
in kinase buffer, then resuspended in kinase buffer
containing 100 mM ATP and the GST-c-Jun substrate.
The reaction proceeded for 30 min at 30°C after which
time the reaction was terminated by the addition of
SDS sample buffer, boiled, and immunoblotted using
phospho-specific c-Jun antibody.
Verification of the kinetics of the kinase active state
of endogenous JNK was accomplished using an im-
mune complex kinase assay. 250 mg of lysate protein
and JNK1 antibody was combined at 4°C overnight.
The immune complex was recovered by centrifugation
after treatment with protein A-conjugated Sepharose
CL-4B as described above. The complex was washed in
lysis buffer, then in kinase buffer, and subsequently
resuspended in kinase buffer containing 100 mM ATP
to which 1 mg of GST-c-Jun substrate was added and
reacted for 30 min at 30°C. The reaction was then
terminated and the extent of JNK-dependent phos-
phorylation of the GST-c-Jun substrate was assayed by
immunoblot using phospho-specific c-Jun antibody re-
active only to phosphorylated serine 63 in the c-Jun
protein. The background levels of the JNK-indepen-
dent phosphorylated fraction of GST-c-Jun were sub-
stracted in the scanning densitometry of the kinetics of
kinase active JNK.
Proteinase assays
Conditioned medium was reserved upon termination
of migration experiments at 24 h. Migration assays
were performed as previously reported by us, (Zeigler
et al., 1996a). The conditioned medium was assayed for
MMP activity by gelatin zymography as previously de-
scribed by us (Zeigler et al., 1996b). Briefly, equivalent
amounts of conditioned medium were resolved by SDS-
PAGE (8.0%) containing 1 mg/ml gelatin as a substrate
to detect the gelatinolytic activity characteristic of
MMP9. After electrophoresis, SDS was removed by
several washes in 1% Triton X-100 and then the wash
was continued overnight so as to renature the enzyme
and recover gelatinolytic activity. Gelatinolytic activity
is observed as a clear zone of gelatin substrate degra-
dation visible after staining the gel with Coomassie
Blue and destaining. In parallel, Western blotting with
MMP-9-specific antibody confirmed the presence of the
92-kD gelatinase in these samples of conditioned me-
dium (data not shown). The differences in the levels of
MMP-9 under various conditions were estimated by
densitometric scanning using the SHARP JX-320 scan-
ner and the NIH Image analysis software program.
MEK/ERK signaling in the presence
of PD098059
In some cultures of keratinocytes, the MEK-specific
inhibitor, PD098059 (Pang et al., 1995), was added to
the 60-mm culture dishes in KBM at the indicated
doses for 30 min. A stock solution of the inhibitor was
prepared in dimethylsulfoxide (DMSO). The medium
was then withdrawn and KBM-containing growth fac-
tor and inhibitor were added to the cultures for a period
of 30 min, after which time cultures were harvested
and lysates prepared and assessed for activity as de-
scribed above.
Transfection of early passage keratinocytes
Keratinocytes were transiently transfected with a
dominant interfering mutant JNK(APF) (Derijard et
al., 1994) generously provided by Roger L. Davis (Uni-
versity of Massachusetts Medical School and HHMI,
Worcester, MA). pcDNA3.1 and/or AP-1/Luc, an AP-1-
dependent luciferase reporter plasmid, was provided
by Stratagene (La Jolla, CA). Transfection of keratin-
ocytes was performed using FuGene6 transfection re-
agent as described (Boehringer Mannheim). The
expression construct was prepared in pcDNA3.1 (In-
vitrogen, Carlsbad, CA) into which the full-length
JNK1 cDNA sequence containing the FLAG epitope-
tag was inserted. JNK1 requires phosphorylation of
Thr(183) and Tyr(185) for activation. The JNK(APF)
expression plasmid contains mutations in the JNK1
activation site in which Ala is substituted for Thr(183)
and Phe is substituted for Tyr(185). As a result of these
substitutions, the mutant JNK1 is rendered kinase
inactive and unable to activate c-Jun. The AP-1 cis-
reporter plasmid consists of the luciferase reporter
gene driven by a consensus promoter sequence (TATA
box) linked to seven tandem repeats of the AP-1 con-
sensus enhancer sequence.
Luciferase reporter assay
Early passage keratinocytes (passage 1) were plated
at 150 3 103 in 35-mm culture dishes and incubated for
24 h. Cells were then transfected at a ratio of 4 ml
FuGene6 reagent to 3 mg of DNA (1.5 mg of pJNK(APF)
or pcDNA3.1 and 1.5 mg of pAP-1/Luciferase reporter
plasmid) or with JNK(APF) alone at a ratio of 4:3 in
modified KGM containing HGF. In the same experi-
ment, cells were also transfected at the same ratio of 4
ml FuGene reagent to 3 mg of DNA as described above
but substituting the pSV/b-galactosidase reporter plas-
mid for the pAP-1/Luciferase reporter plasmid. After
24 h, the transfected cells were harvested by scraping
in Tris-phosphate buffer containing DTT, Triton X-100,
DCTA (diaminocyclohexane tetraacetic acid), and glyc-
erol. Luciferase activity in the lysate was measured as
a function of light production by the enzyme in the
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presence of beetle luciferin as substrate (Promega,
Madison, WI). Luminescence was quantitated using a
luminometer. b-galactosidase activity in cell lysates
was measured as a function of hydrolysis of the color-
less substrate (OPNG) to a colored substrate by b-ga-
lactosidase (Promega). Color formation was monitored
by spectrophotometry. A standard curve of absorbance
as a function of milliunits of b-galactosidase standard
was used to determine the milliunits of enzyme activity
in the lysate samples. Luciferase activity was reported
as relative light units (RLU) normalized to milliunits of
b-galactosidase activity. The results (see Fig. 7A) are
representative of four separate experiments.
Direct assessment of the motility of JNK(APF)
transfected cells
Keratinocytes were transfected with JNK(APF) or
mock transfected as described above. After 24 h, the
cells were harvested and plated at 50 3 103 onto the
upper surface of an uncoated membrane in the upper
chamber of 24-well chambers (Biocoat, Becton Dickin-
son, Bedford, MA). The lower chamber contained either
KBM or HGF in KBM. After 18 h at 37°C, the upper
chamber was scrubbed with cotton swabs to remove
cells that did not migrate. Cells that migrated to the
undersurface of the membrane were subsequently fixed
in 4% paraformaldehyde and then permeabilized with
0.2% Triton X-100. The filters were then rinsed and
cells transfected with JNK(APF) were stained with
FLAG-specific antibody (1:100 dilution) using Vec-
tastain elite reagent kit (Vector Laboratories, Burlin-
game, CA). Mock-transfected cells were stained with
hematoxylin. The number of cells visualized in five
different fields by light microscopy was counted and
reported as the mean cell number per field.
RESULTS
Differences in kinetic properties of the
endogenous MEK and ERK signaling
intermediates in keratinocytes stimulated with
invasion-promoting vs noninvasion-promoting
growth factors
Time-course analyses of endogenous MEK1/2 and
endogenous ERK1/2 activation were performed to de-
termine if differences exist in the kinetic properties of
the signals transmitted by these endogenous signaling
proteins when early passage keratinocytes are stimu-
lated with HGF or EGF as compared to KGF or IGF-1.
To evaluate the kinetics of activation of signaling in-
termediates in both the ERK and JNK pathways, we
used phospho-specific antibodies that recognize only
the kinase active forms of these signaling intermedi-
ates. The representative results of one of three individ-
ual experiments of the kinetics of activation of the
MEK/ERK signaling intermediates are shown accom-
panied by a graphic display of the growth factor-depen-
dent fold increase in MEK and ERK activation (Fig.
1A,B, respectively). Since MEK is the upstream activa-
tor of ERK1/2 (Seger and Krebs, 1995), we first as-
sessed the time-course of MEK activation upon stimu-
lation by each of the four growth factors using phospho-
specific MEK1/2 antibody. As compared to MEK1/2
phosphorylation at time 0 (before stimulation with
growth factor), maximal levels of MEK1/2 activation
are evident by 2 min in keratinocytes stimulated with
all four growth factors. However, only HGF and EGF
maintain a prolonged period of nearly peak activation
of MEK1/2 during 60 min. We also found that this
maximum activity persisted for at least 4 h (data not
shown). In contrast, there is a decline in MEK1/2 acti-
vation in KGF or IGF-1-stimulated keratinocytes to
nearly background levels by 30 min after initial peak
activation at 2 min. It is also apparent that there is no
change in the steady-state (SS) accumulation of endog-
enous MEK1/2 in keratinocytes treated with HGF (Fig.
1A, SS) as determined by immunoblot assays using
phosphorylation state-independent MEK1/2-specific
antibody. Similar results were also obtained with the
other three growth factors (data not shown). These
results indicate that growth factor-specific differences
in the profile of endogenous MEK phosphorylation are
not the result of changes in the steady-state accumu-
lation of MEK protein.
The time-course of endogenous ERK1/2 activation in
keratinocytes treated with each of the four growth fac-
tors was evaluated using phosphorylation state-specific
ERK1/2 antibody. The kinetics of ERK1/2 activation in
cells stimulated with HGF or EGF reveals that maxi-
mum activation is apparent by 10 min, persists with
little change through 60 min, and occurs within 8 min
after the initial peak activation of MEK1/2 (Fig. 1B).
Maximum activity extends through 4 h of stimulation
with either of these two growth factors (data not
shown). In contrast, there is only transient stimulation
of ERK1/2 activation in cells treated with KGF or
IGF-1. While ERK1/2 has been well characterized as
the effector of MEK1/2, these kinetic profiles of endog-
enous MEK1/2 and ERK1/2 activation reveal how
closely linked in time ERK 1/2 activation is with
MEK1/2. Furthermore, these results suggest that the
kinetics of activation are differentially regulated by
different ligand/receptor protein tyrosine kinase inter-
actions. As was the case with MEK1/2 phosphorylation,
the steady-state accumulation of ERK1/2 in cells
treated with these growth factors does not change (Fig.
1B, SS).
To independently verify the kinase active state of
endogenous MEK1/2 in these cell lysates, a kinase cas-
cade assay was performed. Cell lysate protein prepared
from keratinocytes stimulated for 30 min with HGF
was immunoprecipitated with MEK1 and MEK2-spe-
cific antibodies and the immune complex subsequently
reacted with the GST-ERK substrate followed by the
addition of GST-Elk-1. The GST-Elk-1 substrate is a
recombinant form of the endogenous Elk-1 transcrip-
tion factor which is, in vivo, a substrate of active
ERK1/2. Phosphorylation of the GST-Elk-1 substrate is
detected using phosphorylation state-specific Elk-1 an-
tibody which is reactive with the Elk-1 protein only
when phosphorylated at Ser383, its activating site (Fig.
2B). The results of this assay indicate that in the pres-
ence of immunoprecipitated MEK1/2 and GST-ERK,
GST-Elk-1 is phosphorylated (Fig. 2A, lane 1), al-
though there is a modest level of autoactivation of
GST-ERK in the absence of MEK1/2 (lane 3). In the
absence of GST-ERK, but in the presence of immuno-
precipitated enodgenous MEK1/2, GST-Elk-1 is not
phosphorylated (lane 2), indicating that GST-Elk-1
phosphorylation is dependent on the activation of GST-
ERK by kinase-active endogenous MEK1/2.
275ERK AND JNK REGULATION OF MMP-9 LEVELS
An immune complex kinase assay was performed to
test whether MEK1/2-dependent phosphorylation of
ERK1/2 activated endogenous ERK1/2 kinase activity
in HGF-stimulated keratinocytes in a time-dependent
manner as compared to keratinocytes stimulated with
KGF. An immune complex of endogenous ERK1/2 and
phospho-specific ERK1/2 antibody was formed using
cell lysate protein prepared from cells stimulated with
HGF or KGF which were previously assessed for acti-
vation of endogenous ERK1/2 (Fig. 1B). The results
indicate that endogenous ERK1/2 in HGF-stimulated
keratinocytes is kinase active (Fig. 2B). A graphical
representation of the kinetics of kinase-active ERK is
depicted in Figure 2C. The data demonstrate a sus-
tained level of ERK activity, which correlates with the
kinetic profile of endogenous ERK1/2 activation (com-
pare results in Fig. 2B with Fig. 1B). Similar results
were obtained with EGF-stimulated keratinocytes
(data not shown). However, the kinase activity of en-
dogenous ERK1/2 in cells stimulated with KGF is tran-
sient and correlates with the kinetic profile of endoge-
nous ERK1/2 activation by KGF (compare results in
Fig. 2B with Fig. 1B).
Kinetics of endogenous SEK and JNK kinase
activity in growth factor-stimulated
keratinocytes
The invasive response stimulated by HGF or EGF
results in an increase in MMP-9 production (Zeigler et
al., 1996b). We found that an increase in MMP-9 pro-
duction and activation is linked to epidermal kerati-
nocyte invasion of the dermis and that MMP-9 is a
secreted product of HGF- or EGF-stimulated keratino-
cytes (Zeigler et al., 1996a,b). The AP-1 transcription
complex, which includes the c-Jun protein, is appar-
ently essential for transcriptional activation of MMP-9
gene expression (Gum et al., 1997). Because activation
of c-Jun is specifically dependent on the kinase activity
of JNK (Derijard et al., 1994), which in turn is acti-
vated by SEK, the kinetics of activation of endogenous
SEK and JNK were examined. The representative re-
sults of one of three individual experiments are shown
accompanied by graphs depicting the growth factor-
dependent fold increase in SEK and JNK activity (Fig.
3A,B).
The kinetics of activation of endogenous SEK was
evaluated using a kinase cascade assay. This entailed
reacting cell lysate protein, prepared from HGF- or
KGF-stimulated keratinocytes, with a GST-JNK sub-
strate conjugated to glutathione-agarose beads. This
substrate exhibits serine-specific kinase activity to-
ward c-Jun. The recovered GST-JNK substrate, if ac-
tivated by endogenous SEK, will in turn react with the
GST-c-Jun substrate phosphorylating the Ser63/73
codons. Phosphorylation of these two serine residues,
in vivo, regulates the transcriptional activity of c-Jun.
Using the phosphorylation state-specific c-Jun anti-
body, reactive only with activated c-Jun, we were able
to measure the activation kinetics of SEK by assessing
the kinetics of GST-c-Jun phosphorylation.
The results of this SEK-dependent kinase cascade
assay demonstrate that endogenous SEK is activated
Fig. 1. Kinetics of growth factor-
dependent activation of MEK1/2
and ERK1/2 kinase activity. Im-
munoblots of equivalent amounts
of lysate protein (100 mg) prepared
from keratinocytes treated with ei-
ther HGF, EGF, KGF, or IGF-1
and reacted with either phospho-
specific MEK1/2 antibody (A) or
phospho-specific ERK1/2 antibody
(B). SS: The steady-state level of
MEK1/2 protein (A) obtained by
reaction with phosphorylation
state-independent MEK1/2 anti-
body or the steady-state level of
ERK1/2 protein detected by reac-
tion with phosphorylation state-in-
dependent ERK1/2 antibody (B).
Graphical representations of the
kinetics of growth factor-depen-
dent MEK and ERK activation and
SS levels of these proteins are
shown in panels A and B, respec-
tively. Lane MEK-P: Positive con-
trol of activated MEK1/2 in lysate
protein prepared from serum-stim-
ulated NIH3T3. Lane ERK-P: Pos-
itive control consisting of recombi-
nant ERK2 fusion protein (p42)
phosphorylated and activated by
treatment with MEK1/2 in vitro
and purified free of nonphosphory-
lated ERK1/2.
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in keratinocytes stimulated with HGF and the kinetics
of activation reveal a rapid increase to maximal activ-
ity by 10 min and then declines to near basal activity
by 30 min (Fig. 3A, HGF). In contrast, there is virtually
no activation of SEK in cells stimulated with KGF (Fig.
3A, KGF). However, the steady-state levels of SEK do
not change in HGF-stimulated keratinocytes (Fig. 3A,
SS) or in KGF-stimulated keratinocytes (data not
shown). This suggests that the differences in the profile
of GST-c-Jun phosphorylation are the result of differ-
ences in the activation of endogenous SEK kinase ac-
tivity.
We subsequently evaluated the time-course of endog-
enous JNK and c-Jun activation using the phosphory-
lation state-specific antibodies to each of these pro-
teins. Endogenous JNK can be expressed as several
isoforms including JNK1, comprising two isoforms, i.e.,
p46 and p54(g) or JNK2, p54(a). We used the phosphor-
ylation state-specific JNK antibody, reactive only with
the dually phosphorylated Thr183/Tyr185 kinase-acti-
vating amino acids expressed in all three JNK iso-
forms. Our results reveal that peak activation of
JNK(p54) occurs at 30 min and is transient in kerati-
nocytes stimulated with HGF. JNK(p46) appears as a
doublet in which peak activity occurs at 30 min and the
signal appears stronger as compared to JNK(p54) (Fig.
3B, HGF). Unlike JNK(p54), JNK(p46) activation per-
sists through 60 min, despite the rapid decline in SEK
activity. Coincidental with stimulation of endogenous
JNK activation is an increase in the phosphorylation of
endogenous c-Jun in HGF-stimulated keratinocytes,
sharply increasing at 30 min and remaining above
basal levels through 60 min (Fig. 3C, HGF). Similar
results were observed in EGF-stimulated keratinocytes
(data not shown).
In contrast to HGF stimulation, the kinetics of acti-
vation of endogenous JNK, in KGF-stimulated kerati-
nocytes, is markedly different (Fig. 3B, KGF). There is
virtually no increase in JNK activation above basal
levels in keratinocytes not treated with growth factor
(0 min). Instead, there is a progressive decline in phos-
phorylation of JNK below basal levels starting at 10
min and continuing through 60 min. Consistent with
these data, there is no change in the levels of phosphor-
ylation of endogenous c-Jun in KGF-treated keratino-
cytes (Fig. 3C, KGF). There is also no change in the
steady-state levels of the JNK and c-Jun proteins (Fig.
3B,C, SS), indicating that differences in the activation
profiles are not the result of changes in the steady-state
levels of these proteins.
We used a kinase cascade assay to evaluate the ki-
netics of endogenous SEK activation in lysate protein
prepared from HGF-stimulated keratinocytes which
depended upon SEK-specific activation of the exoge-
nous substrate, GST-JNK (Fig. 3A, HGF). To further
confirm that the kinase activation of GST-JNK is de-
pendent on kinase-active endogenous SEK, we per-
formed a SEK kinase activity control assay. In this
experiment, endogenous SEK was immunoprecipitated
with SEK-specific antibody from lysates prepared from
keratinocytes stimulated with HGF at 0, 2, and 10 min.
After reaction of the SEK-depleted lysate protein with
GST-JNK substrate, the kinase activity of this sub-
strate was tested by reaction with GST-c-Jun sub-
strate. As expected, there was no increase in levels of
GST-c-Jun phosphorylation above background levels
(Fig. 4A) as compared to levels of phosphorylation of
GST-c-Jun in SEK-complete lysate protein at 0, 2, and
10 min in HGF-stimulated keratinocytes (Fig. 3A,
HGF).
To directly demonstrate that endogenous JNK is ki-
nase active and is capable of activating endogenous
c-Jun, JNK was immunoprecipitated with JNK-specific
antibody from samples of the same lysate protein used
to assess the kinetics of JNK activation in HGF- or
KGF-stimulated keratinocytes. JNK kinase activity
was then evaluated by assessing changes in the level of
Fig. 2. Assessment of endogenous MEK and ERK kinase activity. A:
Kinase cascade assay in which the endogenous MEK1/2 immune
complex formed with MEK1/MEK2-specific antibodies using lysate
protein prepared frorm HGF-stimulated keratinocytes was reacted
either with the GST-ERK2 substrate (lane 1) or in the absence of this
substrate (lane 2) and GST-Elk-1 substrate. GST-ERK was also re-
acted with GST-Elk-1 to assess the level of autoactivation of GST-
ERK in the absence of endogenous MEK1/2 (lane 3). Phosphorylation
of GST-Elk-1 was detected by immunoblot using phospho-specific
Elk-1 antibody. B: Immune complexes of endogenous ERK1/2 formed
with phospho-specific ERK1/2 antibody from lysate protein prepared
from HGF- or KGF-stimulated keratinocytes at the times indicated
(in minutes) and then reacted with the kinase-inactive substrate,
GST-Elk-1 protein. Phosphorylation of GST-Elk-1 was detected by
immunoblot using phospho-specific Elk-1 antibody. ERK-P Control:
Immunoblot of phosphorylation of GST-Elk-1 when reacted with ki-
nase-active recombinant ERK. C: Graph of the immunoblot of ERK-
dependent phosphorylation of GST-Elk-1 in Figure 2B.
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GST-c-Jun phosphorylation. As depicted in Figure 4B,
the kinetic profile of GST-c-Jun phosphorylation in
HGF- or KGF-treated keratinocytes corresponds to the
kinetic profiles of endogenous JNK activation as previ-
ously shown (Fig. 3B). A graphical representation of
the kinetics of the kinase-active JNK is shown in Fig-
ure 4C.
Although these studies have focused primarily on
the kinetics of two principal members of the MAPK
family of signaling pathways, it should be noted that
we also investigated whether the third principal
member of the MAPK family (the p38 MAPK path-
way) was similarly activated. We found that the ac-
tivated form of p38 MAPK was detected by Western
blot in cell extracts of C-6 glioma cells stimulated
with anisomycin using phosphorylation state-specific
p38 MAPK antibody. However, phosphorylated p38
MAPK was not detected in cell lysates of keratino-
cytes stimulated with either HGF or EGF (data not
shown).
Activated endogenous MEK regulates
keratinocyte migration and MMP-9 production
As we previously reported (Zeigler et al., 1996a), both
HGF and EGF are potent stimulators of epidermal
keratinocyte invasion of the dermis in a human skin
explant model. Furthermore, there is direct correlation
between induction of invasion and stimulation of ke-
ratinocyte motility and production of MMP-9 (Zeigler
et al., 1996a,b). The data depicted above suggest that
expression of these properties in HGF- or EGF-stimu-
Fig. 3. Kinetics of growth factor-
dependent activation of endoge-
nous SEK, JNK, and c-Jun. A: Ki-
nase cascade assay in which 250
mg of lysate protein from HGF- or
KGF-stimulated keratinocytes for
the indicated time intervals was
combined with SEK-specific GST-
JNK substrate conjugated to aga-
rose beads. SEK-dependent activa-
tion of GST-JNK substrate was
then assessed by GST-c-Jun phos-
phorylation levels in immunoblots
using the phospho-specific c-Jun
antibody. Lanes GST-JNK 1 GST-
c-Jun: Combination of these fusion
proteins in a kinase assay in the
absence of lysate protein. Lane
GST-c-Jun: SEK- and JNK-inde-
pendent levels of phosphorylated
GST-c-Jun. B, C: Immunoblots of
equivalent amounts of lysate pro-
tein (100 mg) prepared from kera-
tinocytes treated with either HGF
or KGF, then treated with either
phospho-specific JNK antibody (B)
or phospho-specific c-Jun antibody
(C). Lane SS: The steady-state
level of endogenous SEK, JNK,
and c-Jun in equivalent amounts
of lysate protein in HGF-stimu-
lated keratinocytes assessed by re-
action with phosphorylation state-
independent SEK, JNK, and c-Jun
antibody. The kinetics of SEK,
JNK, and c-Jun activation are dis-
played graphically in panels A, B
and C, respectively. Lane JNK-P:
Positive control of kinase-acti-
vated JNK in lysate protein pre-
pared from UV-treated 293 cells.
Lane c-Jun-P: Positive control of
activated c-Jun in lysate protein
prepared from UV-stimulated NIH
3T3 cells.
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lated keratinocytes is associated with activation of the
MEK/ERK and SEK/JNK signaling modules (Figs. 1, 3,
respectively).
To determine whether the endogenous MEK/ERK
signaling pathway is directly related to these biological
activities, keratinocytes were treated with HGF and a
MEK-specific inhibitor, PD098059 (Pang et al., 1995),
which blocks MEK kinase activity. As shown in Figure
5A, endogenous ERK1/2 activation is inhibited in a
dose-dependent manner in the presence of increasing
amounts of MEK inhibitor. We also demonstrate that
the effect of PD098059 on endogenous MEK1/2 is re-
versible such that kinase activity is regained and re-
sults in an increase in ERK1/2 phosphorylation after
removal of the inhibitor but with continued treatment
of keratinocytes with HGF (Fig. 5A, ERK). Further-
more, MEK1/2 activity also affects the steady-state
levels of c-Fos such that in the presence of PD098059
there is a dose-dependent decrease in c-Fos protein
levels that is also reversible upon removal of the inhib-
itor (Fig. 5A, c-Fos).
Having demonstrated the direct effect of PD098059
on MEK1/2 kinase activity, we also assessed whether
keratinocyte motility is dependent on activated
MEK1/2. In the absence of MEK inhibitor, there is
more than a fivefold increase in the migration of kera-
tinocytes treated with HGF as compared to cells
treated with basal medium containing no growth factor
(KBM) (Fig. 5B). However, with increasing concentra-
tions of PD098059, there is a concentration-dependent
decrease in migration.
The conditioned medium from the migration assay
cultures was reserved and samples of this medium
were assessed for changes in the levels of MMP-9
by gelatin zymography. Consistent with past results
(Zeigler et al., 1996b), there is an increase in the
amount of MMP-9 detected in the conditioned medium
from HGF-stimulated keratinocytes compared to con-
ditioned medium from cells treated with KBM (Fig.
4C). With increasing concentrations of MEK inhibitor,
however, there is a concentration-dependent decrease
in the accumulation of MMP-9. These findings demon-
strate that the MEK/ERK signaling module is neces-
sary for the production of MMP-9 and for the induction
of cell migration of HGF-stimulated keratinocytes.
However, we found that there is no dose-dependent
inhibitory effect of PD098059 on JNK or c-Jun phos-
phorylation compared to its effect on ERK1/2 phosphor-
ylation (Fig. 6). These results show that neither JNK
nor c-Jun are effectors of active MEK1/2 and, further,
confirm that JNK and ERK activity are independent of
each other. These results, however, raise the question
as to the role(s) the JNK signaling pathway plays in
stimulating the invasive response in HGF- or EGF-
stimulated keratinocytes.
The JNK signaling pathway contributes to
activation of the AP-1 complex but is not
required for cell movement
We know from previous studies that the AP-1 en-
hancer sequence in the promoter region of the MMP-9
gene is essential for the induction of MMP-9-specific
mRNA leading to synthesis of MMP-9 protein (Gum et
al., 1996). In light of our findings described above, it
appears that the HGF-stimulated ERK pathway in
early passage keratinocytes regulates c-Fos expression.
We know that the transcriptionally active AP-1 com-
plexes may comprise c-Fos:c-Jun heterodimers (Smeal
et al., 1989). Since we clearly show that c-Jun activa-
tion remains unchanged when MEK1/2 activity is
blocked and that activating phosphorylation of c-Jun is
JNK dependent, then the production of the enodgenous
AP-1 complex and its activation is also dependent on
Fig. 4. Assessment of endogenous SEK and JNK kinase activity. A:
Formation of immune complexes of equivalent amounts of lysate
protein, prepared from keratinocytes stimulated with HGF for 0 min
(lane 1), 2 min (lane 2), and 10 min (lane 3) as depicted in Figure 3,
with SEK-specific antibody conjugated to agarose beads. The SEK-
depleted lysate was recovered then GST-JNK substrate and GST-c-
Jun substrate was added to this lysate as described in Experimental
Procedures. Residual SEK activity was assessed by immunoblot blot
using phospho-specific c-Jun antibody. Lane 4: GST-JNK1GST-c-
Jun: GST-JNK combined with GST-c-Jun in the absence of SEK-
depleted lysate. B: Immune complexes of endogenous JNK protein in
lysates prepared from keratinocytes stimulated with either HGF or
KGF at the times indicated (in minutes) with JNK1-specific antibody
conjugated to agarose beads, then reacted with GST-c-Jun substrate
and immunblotted with phospho-specific c-Jun antibody. Lane GST-
c-Jun: SEK and JNK-independent phosphorylated GST-c-Jun. C:
Graph of the immunoblot of JNK-dependent phosphorylation of GST-
c-Jun in Figure 4B.
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activation of c-Jun by JNK in HGF-stimulated keratin-
ocytes.
To evaluate the role of the JNK signaling pathway in
the activation of the AP-1 complex in HGF-stimulated
keratinocytes, these cells were cotransfected with an in-
terfering mutant form of JNK, designated JNK(APF),
and a luciferase reporter gene, designated AP-1/Luc,
driven by an AP-1 enhancer sequence. The effect of block-
ing endogenous JNK activity on the formation of an ac-
tive AP-1 complex was evaluated by measuring luciferase
activity in these cells. We found that luciferase activity
was blocked by 45% (P , 0.001) as compared to cells
cotransfected with the empty vector (pcDNA3.1) and AP-
1/Luc. These results suggest that formation of an active
AP-1 complex is JNK dependent (Fig. 7A).
We then determined the effect of blocking JNK ac-
tivity on HGF-stimulated keratinocyte motility. The
assessment of changes in the migration of the
JNK(APF)-transfected keratinocyte population can be
directly measured and compared to the migratory ca-
pacity of nontransfected cells. To do this, we used che-
motactic chambers in which JNK(APF)- or mock-trans-
fected cells were stimulated by HGF. JNK(APF) cells
which migrated to the underside of the porous mem-
brane were immunostained with anti-FLAG antibody
reactive to the FLAG-epitope tagged JNK(APF) pro-
tein, while motile, mock-transfected cells were stained
with hematoxylin. We found that the JNK(APF)-trans-
fected cells are motile and are, in fact, approximately
twofold more active than mock-transfected cells (Fig.
7B). In the absence of HGF, no motile JNK(APF)-trans-
fected cells are detected (data not shown).
DISCUSSION
Two essential properties of the invasive response are
the capacity of cells to generate motile forces and the
capacity to produce matrix-degrading proteinases
which enables stimulated cells to penetrate extracellu-
lar matrix barriers. We undertook the studies pre-
sented here to examine the underlying mechanisms
associated with the activation of endogenous interme-
diates in the MAPK signaling pathways which regulate
these complex invasive properties.
While previous reports have presented evidence that
sustained rather than transient activation of the MEK/
ERK signaling cascade leads to induction of cellular
differentiation rather than proliferation (Traverse et
al., 1992; Schramek et al., 1996), the studies we
present here provide convincing evidence that pro-
Fig. 5. The effect of MEK inhibitor(PD098059) on ERK kinase ac-
tivity, cell movement, and MMP-9 production. A: Immunoblots of
samples of lysate protein from keratinocytes stimulated with HGF
either in the absence or presence of PD098059 at the indicated doses
and reacted with either phospho-specific ERK antibody or c-Fos-spe-
cific antibody. Lane REV-HGF: Reversal of PD098059 effect by re-
moval of the inhibitor and continued treatment with HGF for 30 min.
Lane ERK-P: ERK2-positive control as described in Figure 1. B: The
migration of keratinocytes after stimulation for 24 h with HGF in the
absence or presence of PD098059 at the indicated doses. C: Gelatin
zymography of equivalent amounts of conditioned medium from mi-
grating cells in the presence and absence of HGF, with and without
the addition of the inhibitor.
Fig. 6. The effect of MEK inhibitor on endogenous JNK and c-Jun
activation. Immunoblots of samples of lysate protein, used to assess
the effects of PD098059 on MEK and ERK activation in keratinocytes
stimulated with HGF, treated with either phospho-specific JNK an-
tibody or phospho-specific c-Jun antibody.
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longed activation of endogenous MEK/ERK signaling is
required in eliciting invasive responses in epidermal
keratinocytes. Sustained activation initiated by HGF
or EGF is an essential property of the MEK/ERK sig-
naling pathway and is linked to a marked induction in
cell movement and MMP-9 production. This is appar-
ent when comparing the kinetics of activation of the
MEK/ERK signaling module by each of the four growth
factors (Fig. 1). Furthermore, the consequences of pro-
gressive interference of sustained activation of MEK is
a dose-dependent decrease in ERK signaling and a
progressive inhibition of both cell movement and
MMP-9 production (Fig. 5). These results suggest that
persistent activation of endogenous MEK and ERK is
essential in stimulating cell movement and MMP-9
production. Because we previously found no marked
differences in the proliferative responses of these cells
to either the invasion-promoting or noninvasion-pro-
moting growth factors (Zeigler et al., 1996a,b), it is
likely that the mitogenic response in keratinocytes may
be effectively stimulated by transient ERK signaling,
while prolonged activation of the ERK pathway is re-
quired to stimulate invasive properties of cell move-
ment and MMP production.
There are several mechanisms by which prolonged
activation of ERK signaling may be achieved and thus
regulate specific cellular responses. These include over-
expression of cell surface receptors leading to an in-
crease in the number of receptors at the cell surface
(Traverse et al., 1994). Sustained signaling can also
ensure translocation of activated ERK to the nucleus,
thereby maintaining activating levels of transcription
factor activity which stimulate specific cellular re-
sponses (Traverse et al., 1992). However, another im-
portant process in controlling protein kinase activation
is regulated activation or deactivation of protein phos-
phatases. Both kinase-active MEK and ERK are likely
targets that can be negatively regulated by protein
phosphatase 2A and protein tyrosine phosphatases and
may thus modulate the properties of the ERK signaling
pathway (Hunter, 1995). We think that sustained ac-
tivation of ERK signaling in keratinocytes stimulated
by HGF or EGF as compared to KGF or IGF-1 might
reflect differences in the regulation of protein phospha-
tase activity by these growth factors. In keratinocytes
treated with KGF or IGF-1, we consistently found a
level of ERK activity that fell below the level of basal
activity. This occurred as early as 10 min in cells stim-
ulated with KGF or IGF-1 and suggests that transient
ERK signaling by these growth factors may involve
KGF- or IGF-1-dependent activation of phosphatase
activity (Fig. 1B, KGF and IGF-1). In support of these
observations, we have found that costimulation of kera-
tinocytes with KGF and HGF converts HGF-induced
ERK activation in keratinocytes to a transient signal
and leads to a reduction in cell movement (unpublished
data).
The AP-1 complex is essential in the production of
several MMPs including MMP-9 (Sato and Seiki, 1993;
Gum et al., 1996; Quinones et al., 1994; Gutman and
Wasylyk, 1990). c-Jun activation, however, is ERK in-
dependent and, instead, is apparently activated exclu-
sively by a distinct MAPK signaling module, SEK/JNK
(Derijard, 1994). It, therefore, seems reasonable that in
HGF- or EGF-stimulated keratinocytes, coordinate and
prolonged activation of the endogenous JNK as well as
ERK pathways is necessary to generate an increase in
MMP-9 production. Our results show that like ERK,
the activity of the p46 isoform of JNK1 (in contrast to
the p54 isoform) is sustained. In conjunction with our
findings that JNK activation is not affected by blocking
MEK activity (Fig. 6), it is apparent that these path-
ways are activated independently but coordinately in
keratinocytes stimulated by HGF, at least at the level
of MEK and SEK activation (Figs. 2, 4).
Although persistent activation of MEK1/2 is evident
in HGF-stimulated cells, by comparison SEK activa-
tion is transient in these cells (Fig. 3). While the kinet-
ics of ERK activation further confirms its status as an
effector of MEK1/2, the kinetics of JNK activation is
Fig. 7. The effects of dominant negative JNK(APF) on AP-1 activity
and on cell migration in vivo. A: Early passage keratinocytes were
cotransfected with either JNK(APF) and AP-1(Luc) or pcDNA3.1 and
AP-1(Luc) or JNK(APF) alone. RLU of luciferase activity are normal-
ized to b-galactosidase activity in the same cells transfected with a
b-galactosidase reporter plasmid. B: Keratinocytes transfected with
JNK(APF) or mock transfected (MT) were transferred to migration
chambers and treated (1) or not treated (2) with HGF. Migrating
transfected cells expressing the FLAG-tagged JNK(APF) protein in
response to HGF stimulation were immunostained with FLAG-spe-
cific antibody and counted as described in Experimental Procedures.
Mock-transfected cells that migrated in response to HGF were stained
with hematoxylin and counted.
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sustained compared to the transient activation of SEK.
These results raise the question as to whether SEK
functions in vivo in HGF-stimulated keratinocytes as
the principal activator of JNK. A recent report has
shown that JNK activation occurs in homozygous
“knock out” SEK (MKK4)(2/2) embryonic cells when
these cells are exposed to osmotic shock or UV radia-
tion, although the level of activation was reduced rel-
ative to levels in wild-type cells (Yang et al., 1997).
However, in these same studies, it was also shown that
JNK1 activity was suppressed when MKK4(2/2)cells
were treated with anisomycin, heat shock, or when
cotransfected with MEKK1 and JNK1. In a different
set of studies, electrical stimulation of skeletal muscle
contraction was found to result in a persistent kinetic
profile of MKK4 activation which was mirrored in the
kinetics of JNK activation (Aronson et al., 1997). Thus,
the role that SEK(MKK4) plays in JNK activation may
be conditional, i.e., depending on both the cell type and
cellular stimuli. In HGF-stimulated keratinocytes,
transiently activated SEK may share in the initial
phase of JNK activation, while persistent activation of
other SEK isoform(s), such as MKK7, may be necessary
to prolong JNK activation (Tournier et al., 1997; Yao et
al., 1997).
The invasive process is complex. As we have shown
in these studies, it is mediated by the prolonged acti-
vation of at least two members of the MAPK signaling
family. By interfering with the activation of either the
ERK or the JNK pathway in HGF-stimulated kerati-
nocytes, we have been able to characterize their specific
roles in mediating the properties of the invasive re-
sponse. The MEK-specific inhibitor studies reveal that
blocking endogenous MEK1/2 activity suppresses
HGF-stimulated ERK activity, reduces the steady-
state levels of c-Fos, and inhibits MMP-9 production
and cell migration (Fig. 5A–C). MEK inhibition, how-
ever, does not affect continued activation of JNK or its
substrate c-Jun (Fig. 6). While specific and exclusive
activation of c-Jun is mediated by JNK (Derijard et al.,
1994), the activating domain(s) in c-Fos which regu-
lates its transcriptional activity has not been precisely
determined. There is evidence, however, that the Elk-1
transcription factor binds to the promoter region of
c-Fos, thereby inducing c-Fos transcription and AP-1
activation (Cavigelli et al., 1995; Gille et al., 1995a,b;
Chiu et al., 1988). Although JNK-dependent activation
of the Elk-1 transcription factor can lead to induction of
c-Fos expression by JNK, this usually occurs in UV-
stimulated cells. In cells stimulated by growth factors,
Elk-1-mediated c-Fos expression is ERK dependent
(Gille et al., 1995a). The evidence presented in Figures
5 and 6 clearly shows that in HGF-stimulated kerati-
nocytes, c-Fos expression is ERK dependent and JNK
independent. Coordinate activation of both pathways,
then, appears to be necessary for the formation and
activation of the AP-1 complex. Neither pathway is
sufficient by itself to regulate MMP-9 production in
HGF-stimulated keratinocytes.
We utilized a dominant interfering mutant of JNK
[JNK(APF)] in order to characterize the role of endog-
enous JNK in mediating cell movement as well as in
mediating endogenous AP-1 activity which has been
shown to be essential for MMP-9 gene expression. Be-
cause in the cotransfection experiments, the probabil-
ity is high that the majority of transfected cells harbor
both plasmids, AP-1 activity only in the cotransfected
population is measured as a function of luciferase ac-
tivity. We were, therefore, able to demonstrate that
JNK-dependent AP-1 activity is suppressed by nearly
45% (P , 0.001) in JNK(APF)-transfected cells com-
pared to cells transfected with the empty vector (Fig.
7A). It is possible, however, that these results under-
estimate the extent of suppression of AP-1 activity by
JNK(APF) due to the presence of pre-existing active,
endogenous AP-1 complexes. These background levels
of active AP-1 may be due, in part, to the demands of
maintaining the viability of early passage keratino-
cytes as well as levels of transfection efficiency. Be-
cause of these considerations, we were not able to re-
move growth factor supplements for a comparable
length of time as was done in the kinetic studies in
order to return signaling intermediates to basal levels
of activity prior to stimulation.
These data, then, are consistent with JNK(APF) sup-
pressing enodgenous JNK activity as measured by sup-
pression of AP-1 activity. However, JNK(APF)-dependent
inhibition of JNK activity did not suppress the motility of
early passage keratinocytes stimulated by HGF (Fig. 7B).
Unexpectedly, we found that JNK(APF)-transfected cells
are more actively motile than mock-transfected cells.
We speculate that suppression of JNK activity may
indirectly relieve some restriction on the interaction of
active ERK with downstream substrates involved in
the generation of motile forces. In this regard, it was
recently shown that myosin light chain kinase
(MLCK), which is critical to the generation of contrac-
tile forces for cell migration, is a substrate of activated
ERK (Klemke et al., 1997). These results suggest that
activation of downstream targets of signals mediated
by MEK/ERK signaling cascade may be all that is
necessary to stimulate cell motility.
On the basis of the evidence presented here, it ap-
pears that the two MAPK pathways, ERK and JNK,
are utilized differently in mediating the invasion-asso-
ciated properties of cell motility and MMP-9 production
in epidermal keratinocytes. The implications of these
findings are that the JNK pathway is necessary for
AP-1 activity which is essential for MMP-9 production
but does not have a role in inducing cell motility in
HGF- or EGF-stimulated keratinocytes. However, the
ERK signaling pathway in HGF- or EGF-stimulated
keratinocyte has a crucial role in the control of both
properties of the invasive process. In this regard, strat-
egies to block signaling via the MEK/ERK pathway
could, in theory, disrupt both cell movement and break-
down of extracellular matrix barriers, thus controlling
the invasive response in squamous epithelial cells. Fur-
thermore, our kinetic studies, suggesting that signal
duration is an essential property in mediating kerati-
nocyte cell movement and MMP production, support
the use of strategies for controlling the invasive process
that do not require complete suppression of signaling.
Instead, a method for converting MEK/ERK signaling
to a transient phenotype may be sufficient in control-
ling the invasive response. A singular advantage of
such a strategy is that transient signaling necessary
for maintenance of other cellular responses is left in-
tact.
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